20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org

What Is BioGenerator?

BioGenerator is an evergreen investor that creates, grows, and funds innovative companies and talented entrepreneurs in the St. Louis region. BioGenerator identifies and de-risks commercially promising innovations and services; advises innovators and entrepreneurs; recruits and supports entrepreneurial talent; makes staged investments grounded in rigorous due diligence; and offers access to enabling lab space and capital equipment. We position companies to navigate the unique challenges of early-stage bioscience company development.

BioGenerator is the investment arm of BioSTL

Adarza is a next-generation multiplex immunoassay product company focused on applications in life science tools and the in vitro diagnostics markets. Adarza’s products and services utilize its proprietary Arrayed Imaging Reflectometry™ (“AIR”) detection platform that is capable of rapid identification and quantification and offers key performance benefits in multiplexing, sensitivity, speed, sample size, dynamic range, and ease of use while affording industry-leading low cost. The AIR platform addresses many commercial applications, including disease biomarkers, personalized medicine, drug and vaccine development, allergy, immunology, and infectious diseases research.

Our Companies

The BioGenerator portfolio is a compilation of companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT.

Our Companies

The BioGenerator portfolio includes companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT.

BioGenerator Company Adarza BioSystems Closes $17M Series C01/19/2017

BioGenerator Company Tioma Therapeutics Raises $86M08/16/2016

MediBeacon Inc. Acquires Mannheim Pharma & Diagnostics06/14/2016

2015 BioGenerator Annual Report Release05/19/2016

BioGenerator Invests in Innovative Health IT Company, MedAware Solutions03/22/2016

BioGenerator Invests in New Immunotherapy Company, Unleash02/18/2016

BioGenerator Portfolio Company Galera Therapeutics Raises $42 Million Series B02/05/2016

BioGenerator Leads Investment in Accuronix Therapeutics01/27/2016

See All News

What Others Are Saying

danwatkins
Wally
gregvygantas

Stay Updated

Stay up to date with the latest BioGenerator news and details.